Skip to main content
. 2020 Nov 20;20:488. doi: 10.1186/s12877-020-01877-1

Table 5.

Model 2: Results of linear mixed model for effect of dementia (CDR-SoB) measured longitudinally on P-ADL level over time

Covariates Unadjusted models Adjusted models
Regr. coeff. (SE) p-value1 Regr. coeff. (SE) p-value1
Effect of main variable
 Time 0.25 (0.12) 0.038 0.27 (0.12) 0.021
 Time*Time 0.005 (0.009) 0.580 − 0.0004 (0.009) 0.964
 Time*Time*Time −0.0002 (0.0002) 0.267 −0.00007 (0.0002) 0.687
 CDR-SoB 0.61 (0.05) < 0.001 0.55 (0.05) < 0.001
 Time*CDR-SoB −0.01 (0.01) 0.242 −0.01 (0.01) 0.193
 Time*Time*CDR-SoB 0.0001 (0.0008) 0.887 0.0003 (0.0008) 0.672
 Time*Time*Time* CDR-SoB 0.000006 (0.00002) 0.704 −0.00000001 (0.00002) 0.996
Effect of additional variables at baseline
Socio–demographic information
  Age (per years) 0.003 (0.02) 0.886 0.01 (0.02) 0.530
  Women −0.49 (0.33) 0.143 −0.23 (0.32) 0.476
  Single −0.65 (0.30) 0.028 −0.46 (0.29) 0.116
Effect of additional variables measured longitudinally
GMHR
  Poor / Fair (Good/Excellent– ref.) 2.04 (0.16) < 0.001 1.77 (0.16) < 0.001
NPI-NH
  Agitation sub-syndrome 0.07 (0.01) < 0.001 0.04 (0.01) 0.002
  Psychosis sub-syndrome 0.07 (0.02) 0.001 −0.002 (0.02) 0.915
  Affective sub-syndrome 0.11 (0.02) < 0.001 0.06 (0.02) 0.001
  Apathy 0.22 (0.03) < 0.001 0.14 (0.03) < 0.001
Use of psychotropic medication
  Antipsychotics 0.19 (0.26) 0.450 0.08 (0.24) 0.730
  Antidepressants −0.003 (0.21) 0.988 − 0.17 (0.20) 0.391
  Anxiolytics 0.06 (0.22) 0.780 0.03 (0.21) 0.894
  Hypnotics/Sedatives 0.42 (0.21) 0.041 0.17 (0.20) 0.382
  Anti-dementia medication −1.44 (0.22) < 0.001 −1.17 (0.21) < 0.001
NH Characteristics
  RU (vs SCU) 0.71 (0.24) 0.003 0.59 (0.23) 0.009

CDR-SoB: The sum score of the domains in the Clinical Dementia Rating scale, BL: Baseline, GMHR: General Medical Health rating scale, NPI-NH: Neuropsychiatric Inventory 12-item Nursing Home version, NH: Nursing home, RU: Regular unit, SCU: Special care unit

N = 515 at T1, N = 383 at T2, N = 320 at T3, N = 241 at T4, N = 212 at T5, N = 157 at T6, N = 121 at T7

T1: baseline, T2: 6-month assessment, T3: 12-month assessment, T4: 18-month assessment, T5: 24-month assessment, T6: 30-month assessment, T7: 36-month assessment

1Bold text indicate p-value < 0.05